Date: 2003-01-01
Source: BioDetection Systems



BioDetection Systems B.V. is a Dutch biotech company providing bioassays based around its core Chemically Activated Luciferase Expression (CALUX^®) reporter gene technology. CALUX^® is marketed in North Amerca under the BioLuc™ trademark.

BDS’ BioLuc™ bioassays are available for:

 • Dioxins
 • Estrogens
 • Androgens
 • Progestins

Pipeline:

 • Thyroid hormones
 • Retinoids
 • Immune response

BDS’ dioxins responsive DR-BioLuc™ is the only bioassay that meets the performance requirements of new EU food and feed legislation.By mimicking toxicological pathways, BDS' BioLuc™ bioassays are being used in drug candidate screening and as substitutes for in-vivo testing.

By mimicking toxicological pathways, BDS' BioLuc™ bioassays are being used in drug candidate screening and as substitutes for in-vivo testing.

See www.toxicology.org for more information about the conference.

<< other articles